(Date:11/20/2008)... 60,000 Americans were infected last year , ...ars after U.S. health officials recommended routin... remains hit-and-miss, and the AIDS epidemic march...es and better testing methods, according to partic... The meeting was designed to review the state of t...
(Date:11/20/2008)...Construction Plan and Begins Marketing; John Stron...chasing Group, Consorta, Inc., to Lead Sales and M...ewswire/ -- The world,s first permanent internatio...ll open in less than five years, the key players d...dtown Manhattan tower have been finalized and mark...
(Date:11/20/2008)...ire/ -- Emerson Ecologics, LLC today,announced th...s, Inc., also,known as TIDhealth, of Redlands, CA...supplements to the professional integrative health...nd TIDhealth creates the leading U.S. provider,of...he high-growth,professional nutritional supplemen...
(Date:11/20/2008)...swire/ -- Want to lower your risk for type,2 diab...an make a big,difference. A study called the Diab... just 5 to 10 percent of your weight can prevent o...pound person, 5 percent is just 9,pounds. , ...ave diabetes, and heart,disease is the leading ca...
Breaking Medicine News(10 mins):Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 2Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 3Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 4Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 5Health News:Emerson Ecologics Announces Acquisition of TIDhealth 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 3Health News:The 5-Percent Plan: Preventing Diabetes and Heart Disease 2(Date:11/20/2008)...REINACH, Switzerland, November 20 /PRNewswire-Firs... the Anti-infective Drugs Advisory Committee of th...ed 17 to 2 against the,approval of intravenous ic...,the treatment of patients with complicated skin ... those caused by methicillin-resistant Staphylococ...
(Date:11/20/2008)...RIDGE, Mass., Nov. 20 Radius Healt... additional $15 million to its second institutiona...tment to $82.5 million and the total amount raised...All existing institutional investors participated ...Fund and including MPM Capital, The Wellcome Trust...
(Date:11/19/2008)...FRANCISCO, Nov. 19 Posit Science C...ence at the Society for Neuroscience,Annual Confe...cognitive,training may benefit Baby Boomers. The...s Program (TM) uses adaptive exercises that target...e designed to drive generalized,improvements in c...
(Date:11/19/2008)...ROCHELLE, N.Y., Nov. 19 Biotech sc...logies to toxicology research to better understand... of organ systems, reports Genetic Engineering &a...ly interested in figuring out a new compound,s mec...ctive toxicology technique, according to the Novem...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in Italy 21277 1SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in Italy 21277 2SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in Italy 21277 3Sequential R CHOP and Ibritumomab Tiuxetan 28Zevalin 28R 29 29 Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreate 2359 1Sequential R CHOP and Ibritumomab Tiuxetan 28Zevalin 28R 29 29 Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreate 2359 2Sequential R CHOP and Ibritumomab Tiuxetan 28Zevalin 28R 29 29 Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreate 2359 3Sequential R CHOP and Ibritumomab Tiuxetan 28Zevalin 28R 29 29 Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreate 2359 4Experts to Develop National Response to Growing Crisis of Premature Birth 21273 1Experts to Develop National Response to Growing Crisis of Premature Birth 21273 2Synthetic Biology 3A funders move to address social and ethical challenges 3573 1Synthetic Biology 3A funders move to address social and ethical challenges 3573 2...L Limited,today announced results from a study pub...ciation that suggest infusions of a novel,new drug...;,cholesterol) levels, may reduce the amount of pl...ecent episode of acute,coronary syndrome (ACS). , ...n,Atherosclerosis – Safety and Efficacy (ERA...
... 2007 - Interleukin,Genetics, Inc. (AMEX:ILI) and ...Diego today reported at the American College of,Ca...coronary artery,disease (CAD) and both oxidized ph...ependent on pro-inflammatory variants of the,inter...The Influence of Oxidized,Phospholipids and Lp(a) ...
Other Medicine Technology:CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum.
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine.
For quantitative determination of amylase in human serum.
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2).
Medicine Products: